| # | Drug | Count |
|---|---|---|
| 0 | EPOPROSTENOL | 43 |
| 1 | TREPROSTINIL | 38 |
| 2 | MACITENTAN | 33 |
| 3 | SILDENAFIL CITRATE | 32 |
| 4 | AMBRISENTAN | 24 |
| 5 | SILDENAFIL | 24 |
| 6 | TADALAFIL | 24 |
| 7 | 0XYGEN | 19 |
| 8 | OXYGEN | 19 |
| 9 | FUROSEMIDE | 18 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EPOPROSTENOL | 43 | 0.0033 |
| 1 | ALCLOMETASONE DIPROPIONATE | 1 | 0.0032 |
| 2 | TOLCAPONE | 1 | 0.0028 |
| 3 | SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE | 2 | 0.0026 |
| 4 | GOLODIRSEN | 1 | 0.0020 |
| 5 | CASIMERSEN | 2 | 0.0020 |
| 6 | DOCUSATE SODIUM 50 MG SENNOSIDES 8.6 MG | 1 | 0.0013 |
| 7 | SENNOSIDES 8.6MG AND DOCUSATE SODIUM 50MG | 1 | 0.0013 |
| 8 | DOCUSATE SODIUM 50MG AND SENNOSIDES 8.6MG | 1 | 0.0011 |
| 9 | OXACILLIN SODIUM | 1 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Prostacycline Vasodilator [EPC] | 77 |
| 1 | Endothelin Receptor Antagonist [EPC] | 54 |
| 2 | Phosphodiesterase 5 Inhibitor [EPC] | 37 |
| 3 | Loop Diuretic [EPC] | 26 |
| 4 | Aldosterone Antagonist [EPC] | 15 |
| 5 | Osmotic Laxative [EPC] | 14 |
| 6 | Proton Pump Inhibitor [EPC] | 12 |
| 7 | Factor Xa Inhibitor [EPC] | 11 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 11 |
| 9 | Soluble Guanylate Cyclase Stimulator [EPC] | 11 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Prostacycline Vasodilator [EPC] | 77 | 0.0006 |
| 1 | Type I Interferon Receptor Antagonist [EPC] | 1 | 0.0005 |
| 2 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 3 | Soluble Guanylate Cyclase Stimulator [EPC] | 11 | 0.0003 |
| 4 | Phosphodiesterase 5 Inhibitor [EPC] | 37 | 0.0003 |
| 5 | Carnitine Analog [EPC] | 1 | 0.0003 |
| 6 | Endothelin Receptor Antagonist [EPC] | 54 | 0.0003 |
| 7 | Provitamin D2 Compound [EPC] | 8 | 0.0003 |
| 8 | Antisense Oligonucleotide [EPC] | 3 | 0.0003 |
| 9 | Prostacyclin Receptor Agonist [EPC] | 6 | 0.0002 |